Alain Vergnenègre
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 11, 2020
Economic analyses of immune-checkpoint inhibitors to treat lung cancer.Alain Vergnenegre, Christos Chouaid
|Jan 11, 2020
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).Alain Vergnenègre, Victor Basse, Gwenaelle Le Garff
|Nov 21, 2019
Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04).Alain Vergnenegre, Margaux Geier, Florian Guisier
|Sep 04, 2018
Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review.Paul Lesueur, Isabelle Martel-Laffay, Alexandre Escande
|Jun 06, 2018
Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC).Alain Vergnenègre, Christos Chouaïd
Pageof 1
